Running a AVBP wheel strategy lets you generate consistent premium income on ArriVent BioPharma Inc while setting your own entry and exit prices on the underlying. ArriVent BioPharma Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own AVBP, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best AVBP wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on AVBP, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable AVBP wheel from a losing one.
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc.
The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the AVBP wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your AVBP wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
